0000899243-20-009124.txt : 20200320
0000899243-20-009124.hdr.sgml : 20200320
20200320163049
ACCESSION NUMBER: 0000899243-20-009124
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200319
FILED AS OF DATE: 20200320
DATE AS OF CHANGE: 20200320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kuwahara Jon
CENTRAL INDEX KEY: 0001664784
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36620
FILM NUMBER: 20732344
MAIL ADDRESS:
STREET 1: 21250 HAWTHORNE BOULEVARD
STREET 2: SUITE 800
CITY: TORRANCE
STATE: CA
ZIP: 90503
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Novus Therapeutics, Inc.
CENTRAL INDEX KEY: 0001404281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 949-238-8090
MAIL ADDRESS:
STREET 1: 19900 MACARTHUR BLVD.
STREET 2: SUITE 550
CITY: IRVINE
STATE: CA
ZIP: 92612
FORMER COMPANY:
FORMER CONFORMED NAME: Tokai Pharmaceuticals Inc
DATE OF NAME CHANGE: 20070622
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-19
0
0001404281
Novus Therapeutics, Inc.
NVUS
0001664784
Kuwahara Jon
C/O NOVUS THERAPEUTICS, INC.
19900 MACARTHUR BLVD., SUITE 550
IRVINE
CA
92612
0
1
0
0
See Remarks
Stock Option (Right to Buy)
0.26
2020-03-19
4
A
0
50000
0.00
A
2030-03-19
Common Stock
50000
50000
D
This option represents a right to purchase a total of 50,000 shares of the Issuer's Common Stock, one quarter of which will become fully vested and exercisable on March 19, 2021, with the remaining 37,500 shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Senior Vice President of Finance and Administration
/s/ Ryan A. Murr, as attorney-in-fact for Jon Kuwahara
2020-03-20